Literature DB >> 10970718

The potential role of fatty acids in attention-deficit/hyperactivity disorder.

A J Richardson1, B K Puri.   

Abstract

As currently defined, attention-deficit/hyperactivity disorder (ADHD) encompasses a broad constellation of behavioural and learning problems and its definition and diagnosis remain controversial. The aetiology of ADHD is acknowledged to be both complex and multifactorial. The proposal considered here is that at least some features of ADHD may reflect an underlying abnormality of fatty acid metabolism. Clinical and biochemical evidence is discussed which suggests that a functional deficiency of certain long-chain polyunsaturated fatty acids could contribute to many of the features associated with this condition. The implications in terms of fatty acid treatment proposals are also discussed; such a form of treatment is relatively safe compared to existing pharmacological interventions, although further studies are still needed in order to evaluate its potential efficacy in the management of ADHD symptoms. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970718     DOI: 10.1054/plef.2000.0196

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  17 in total

1.  Monitoring the oxidation of docosahexaenoic acid in lipids.

Authors:  Ann-Marie Lyberg; Ezio Fasoli; Patrick Adlercreutz
Journal:  Lipids       Date:  2005-09       Impact factor: 1.880

2.  Effect of diet on brain metabolites and behavior in spontaneously hypertensive rats.

Authors:  Ana A Liso Navarro; Elif M Sikoglu; Cailin R Heinze; Ryan C Rogan; Vivienne A Russell; Jean A King; Constance M Moore
Journal:  Behav Brain Res       Date:  2014-05-19       Impact factor: 3.332

3.  Differential effects of modulation of docosahexaenoic acid content during development in specific regions of rat brain.

Authors:  Beth Levant; Marlies K Ozias; Karra A Jones; Susan E Carlson
Journal:  Lipids       Date:  2006-05       Impact factor: 1.880

Review 4.  Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders.

Authors:  Alexandra J Richardson
Journal:  Lipids       Date:  2004-12       Impact factor: 1.880

Review 5.  Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Authors:  Donna Gillies; John Kh Sinn; Sagar S Lad; Matthew J Leach; Melissa J Ross
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

6.  Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study.

Authors:  Stacey Ageranioti Bélanger; Michel Vanasse; Schohraya Spahis; Marie-Pierre Sylvestre; Sarah Lippé; François L'heureux; Parviz Ghadirian; Catherine-Marie Vanasse; Emile Levy
Journal:  Paediatr Child Health       Date:  2009-02       Impact factor: 2.253

Review 7.  Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children.

Authors:  Jan Philipp Schuchardt; Michael Huss; Manuela Stauss-Grabo; Andreas Hahn
Journal:  Eur J Pediatr       Date:  2009-08-12       Impact factor: 3.183

8.  A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.

Authors:  Catherine Cornu; Catherine Mercier; Tiphanie Ginhoux; Sandrine Masson; Julie Mouchet; Patrice Nony; Behrouz Kassai; Valérie Laudy; Patrick Berquin; Nathalie Franc; Marie-France Le Heuzey; Hugues Desombre; Olivier Revol
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-10-05       Impact factor: 4.785

Review 9.  Global epidemiology of mental disorders: what are we missing?

Authors:  Amanda J Baxter; George Patton; Kate M Scott; Louisa Degenhardt; Harvey A Whiteford
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

10.  Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study.

Authors:  Ashley L Colter; Caroline Cutler; Kelly Anne Meckling
Journal:  Nutr J       Date:  2008-02-14       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.